vs

Side-by-side financial comparison of HARTE HANKS INC (HHS) and Ispire Technology Inc. (ISPR). Click either name above to swap in a different company.

HARTE HANKS INC is the larger business by last-quarter revenue ($39.9M vs $20.3M, roughly 2.0× Ispire Technology Inc.). HARTE HANKS INC runs the higher net margin — 5.5% vs -32.5%, a 38.1% gap on every dollar of revenue. On growth, HARTE HANKS INC posted the faster year-over-year revenue change (-15.4% vs -51.5%). HARTE HANKS INC produced more free cash flow last quarter ($-686.0K vs $-4.0M). Over the past eight quarters, HARTE HANKS INC's revenue compounded faster (-6.4% CAGR vs -17.8%).

Harte Hanks is a global marketing services company headquartered in Boston, Massachusetts. Harte Hanks services include analytics, strategy, marketing technology, creative services, digital marketing, customer care, direct mail, logistics, and fulfillment.

Ispire Technology Inc. is a global tech firm specializing in R&D, manufacturing and sales of advanced vaporization hardware and supporting consumables. It serves nicotine and legal cannabis consumer markets, operates two core segments of hardware and branded cannabis products, covers North America, Europe and Asia-Pacific, delivering compliant innovative vapor solutions for B2B partners and end users.

HHS vs ISPR — Head-to-Head

Bigger by revenue
HHS
HHS
2.0× larger
HHS
$39.9M
$20.3M
ISPR
Growing faster (revenue YoY)
HHS
HHS
+36.1% gap
HHS
-15.4%
-51.5%
ISPR
Higher net margin
HHS
HHS
38.1% more per $
HHS
5.5%
-32.5%
ISPR
More free cash flow
HHS
HHS
$3.4M more FCF
HHS
$-686.0K
$-4.0M
ISPR
Faster 2-yr revenue CAGR
HHS
HHS
Annualised
HHS
-6.4%
-17.8%
ISPR

Income Statement — Q4 FY2025 vs Q2 FY2026

Metric
HHS
HHS
ISPR
ISPR
Revenue
$39.9M
$20.3M
Net Profit
$2.2M
$-6.6M
Gross Margin
17.1%
Operating Margin
-0.3%
-33.9%
Net Margin
5.5%
-32.5%
Revenue YoY
-15.4%
-51.5%
Net Profit YoY
17.4%
EPS (diluted)
$0.30
$-0.12

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HHS
HHS
ISPR
ISPR
Q4 25
$39.9M
$20.3M
Q3 25
$39.5M
$30.4M
Q2 25
$38.6M
$20.1M
Q1 25
$41.6M
$26.2M
Q4 24
$47.1M
$41.8M
Q3 24
$47.6M
$39.3M
Q2 24
$45.0M
$37.3M
Q1 24
$45.4M
$30.0M
Net Profit
HHS
HHS
ISPR
ISPR
Q4 25
$2.2M
$-6.6M
Q3 25
$-2.3M
$-3.3M
Q2 25
$-335.0K
$-14.8M
Q1 25
$-392.0K
$-10.9M
Q4 24
$-8.0M
Q3 24
$142.0K
$-5.6M
Q2 24
$-27.8M
$-3.5M
Q1 24
$-171.0K
$-5.9M
Gross Margin
HHS
HHS
ISPR
ISPR
Q4 25
17.1%
Q3 25
17.0%
Q2 25
12.3%
Q1 25
18.2%
Q4 24
18.5%
Q3 24
19.5%
Q2 24
28.3%
Q1 24
20.4%
Operating Margin
HHS
HHS
ISPR
ISPR
Q4 25
-0.3%
-33.9%
Q3 25
1.3%
-8.9%
Q2 25
0.1%
-72.7%
Q1 25
-0.1%
-40.4%
Q4 24
-3.3%
-17.6%
Q3 24
4.0%
-13.4%
Q2 24
3.0%
-9.2%
Q1 24
0.8%
-18.8%
Net Margin
HHS
HHS
ISPR
ISPR
Q4 25
5.5%
-32.5%
Q3 25
-5.8%
-10.7%
Q2 25
-0.9%
-73.4%
Q1 25
-0.9%
-41.5%
Q4 24
-19.1%
Q3 24
0.3%
-14.2%
Q2 24
-61.8%
-9.4%
Q1 24
-0.4%
-19.7%
EPS (diluted)
HHS
HHS
ISPR
ISPR
Q4 25
$0.30
$-0.12
Q3 25
$-0.31
$-0.06
Q2 25
$-0.05
$-0.26
Q1 25
$-0.05
$-0.19
Q4 24
$-0.31
$-0.14
Q3 24
$0.02
$-0.10
Q2 24
$-3.84
$-0.07
Q1 24
$-0.02
$-0.11

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HHS
HHS
ISPR
ISPR
Cash + ST InvestmentsLiquidity on hand
$5.6M
$17.6M
Total DebtLower is stronger
Stockholders' EquityBook value
$20.5M
$-7.7M
Total Assets
$91.8M
$84.4M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HHS
HHS
ISPR
ISPR
Q4 25
$5.6M
$17.6M
Q3 25
$6.5M
$22.7M
Q2 25
$4.8M
$24.4M
Q1 25
$9.0M
$23.5M
Q4 24
$9.8M
$34.4M
Q3 24
$5.9M
$37.7M
Q2 24
$11.0M
$35.1M
Q1 24
$11.5M
$39.5M
Stockholders' Equity
HHS
HHS
ISPR
ISPR
Q4 25
$20.5M
$-7.7M
Q3 25
$19.9M
$-1.8M
Q2 25
$22.2M
$604.7K
Q1 25
$21.4M
$14.8M
Q4 24
$21.7M
$24.2M
Q3 24
$21.0M
$30.7M
Q2 24
$20.6M
$34.5M
Q1 24
$20.0M
$35.9M
Total Assets
HHS
HHS
ISPR
ISPR
Q4 25
$91.8M
$84.4M
Q3 25
$92.7M
$96.4M
Q2 25
$95.0M
$102.2M
Q1 25
$100.6M
$115.7M
Q4 24
$101.8M
$132.0M
Q3 24
$108.1M
$129.0M
Q2 24
$109.7M
$122.6M
Q1 24
$113.4M
$108.0M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HHS
HHS
ISPR
ISPR
Operating Cash FlowLast quarter
$737.0K
$-4.0M
Free Cash FlowOCF − Capex
$-686.0K
$-4.0M
FCF MarginFCF / Revenue
-1.7%
-19.9%
Capex IntensityCapex / Revenue
3.6%
0.3%
Cash ConversionOCF / Net Profit
0.33×
TTM Free Cash FlowTrailing 4 quarters
$-4.5M
$-14.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HHS
HHS
ISPR
ISPR
Q4 25
$737.0K
$-4.0M
Q3 25
$3.2M
$-1.2M
Q2 25
$-4.8M
$4.7M
Q1 25
$-818.0K
$-12.5M
Q4 24
$4.0M
$-3.2M
Q3 24
$-2.9M
$3.6M
Q2 24
$1.6M
$-1.4M
Q1 24
$-5.7M
$3.4M
Free Cash Flow
HHS
HHS
ISPR
ISPR
Q4 25
$-686.0K
$-4.0M
Q3 25
$2.2M
$-1.2M
Q2 25
$-5.1M
$3.7M
Q1 25
$-923.0K
$-12.7M
Q4 24
$3.4M
$-3.2M
Q3 24
$-4.9M
$3.3M
Q2 24
$926.0K
$-2.2M
Q1 24
$-6.2M
$3.3M
FCF Margin
HHS
HHS
ISPR
ISPR
Q4 25
-1.7%
-19.9%
Q3 25
5.5%
-3.9%
Q2 25
-13.1%
18.6%
Q1 25
-2.2%
-48.4%
Q4 24
7.3%
-7.7%
Q3 24
-10.2%
8.5%
Q2 24
2.1%
-5.9%
Q1 24
-13.7%
10.9%
Capex Intensity
HHS
HHS
ISPR
ISPR
Q4 25
3.6%
0.3%
Q3 25
2.5%
0.0%
Q2 25
0.6%
4.8%
Q1 25
0.3%
0.7%
Q4 24
1.3%
0.1%
Q3 24
4.0%
0.7%
Q2 24
1.5%
2.0%
Q1 24
1.2%
0.3%
Cash Conversion
HHS
HHS
ISPR
ISPR
Q4 25
0.33×
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
-20.76×
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

HHS
HHS

Fulfillment And Logistics Services$17.3M43%
Customer Care$13.7M34%
Other$8.9M22%

ISPR
ISPR

Segment breakdown not available.

Related Comparisons